Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Zhou, H. Ye, Q.

Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Yuan, Z. Shao, Z. Ma, L. Guo, R.

Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Chenchula, S. Amerneni, K. C. Ghanta, M. K. Padmavathi, R. Chandra, M. B. Adusumilli, M. B. Chavan, M. Mudda, S. Gupta, R. Lakhawat, B.

Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.

Common Characteristics of Shoulder Injury Related to Vaccine Administration (SIRVA) Following COVID-19 Vaccination: A Comprehensive Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Oketch, Sandra Y. Ochomo, Edwin O. Orwa, Jeniffer A. Mayieka, Lilian M. Abdullahi, Leila H.

Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis

  • Africa
  • Adolescents
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Liyew, A. M. Gilmour, B. Clements, A. C. A. Alene, K. A.

Comparative effectiveness of interventions for preventing tuberculosis: systematic review and network meta-analysis of interventional studies

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wang, X. Haeussler, K. Spellman, A. Phillips, L. E. Ramiller, A. Bausch-Jurken, M. T. Sharma, P. Krivelyova, A. Vats, S. Van de Velde, N.

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Lin, R. Jin, H. Fu, X.

Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Hossaini, S. Keramat, F. Cheraghi, Z. Zareie, B. Doosti-Irani, A.

Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Barbateskovic, M. Klingenberg, S. L. Krauss, S. R. Kong, D. Wu, Z. Petersen, S. B. Kenfelt, M. Gluud, C.

Concentrations, Number of Doses, and Formulations of Aluminium Adjuvants in Vaccines: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...